Sherene Loi, Erika P. Hamilton, Komal L. Jhaveri, Carey K. Anders, Peter Schmid, Ming-Shen Dai, Manuel Ruiz-Borrego, Charles Andreé Joseph de Pádua, Bogdan Zurawski, Claudio Zamagni, Mahmut Gümüş, Sudeep Gupta, Sarice Renee Boston, Adam Konpa, Annie Darilay, Giulia Fabbri, Fabrice André. "Trastuzumab deruxtecan (T-DXd) + durvalumab (D) in patients (pts) with previously untreated HER2+ unresectable/metastatic breast cancer (mBC): Final analysis from DESTINY-Breast07.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.1012